RATIONALE: There are limited longitudinal data about respiratory morbidity and lung function after preterm birth into adulthood. OBJECTIVES: To determine the evolution of respiratory symptoms, spirometry, and airway hyperresponsiveness of ex-preterm subjects from childhood into adulthood. METHODS: Ex-preterm subjects (median birth weight, 1,440 g; median gestation, 31.5 wk), recruited at birth (not treated with surfactant), had excess respiratory symptoms, airway obstruction, and increased airway hyperresponsiveness in mid-childhood. At a median age of 21.7 years, 60 of these subjects (the index study group) and 50 healthy term control subjects were recruited to determine respiratory morbidity and spirometry. MEASUREMENTS AND MAIN RESULTS: Respiratory symptom questionnaire, spirometry, and methacholine challenge test. The index study group had significantly more respiratory symptoms (16 of 60) than did control subjects (4 of 50) (odds ratio, 4.2; 95% confidence interval, 1.3 to 13.5; P = 0.01), but no significant difference in measured spirometry. Specifically, in the index study group and control subjects, the mean z scores (95% confidence interval of the group difference) for the FEV(1) were -0.60 and -0.58 (-0.44 to 0.49), respectively (P = 0.92); for the forced mid-expiratory flow they were -1.02 and -0.86 (-0.33 to 0.64), respectively (P = 0.52); and for the FVC they were -0.29 and -0.33 (-0.46 to 0.38), respectively (P = 0.85). Ex-preterm adults did not show evidence of increased airway hyperresponsiveness compared with control subjects, 23 and 19%, respectively (P = 0.89). CONCLUSIONS: There are still excess respiratory symptoms 21 years after preterm birth. Reassuringly, this longitudinal study did not show evidence of persistent airway obstruction or airway hyperresponsiveness in ex-preterm adults.
RATIONALE: There are limited longitudinal data about respiratory morbidity and lung function after preterm birth into adulthood. OBJECTIVES: To determine the evolution of respiratory symptoms, spirometry, and airway hyperresponsiveness of ex-preterm subjects from childhood into adulthood. METHODS: Ex-preterm subjects (median birth weight, 1,440 g; median gestation, 31.5 wk), recruited at birth (not treated with surfactant), had excess respiratory symptoms, airway obstruction, and increased airway hyperresponsiveness in mid-childhood. At a median age of 21.7 years, 60 of these subjects (the index study group) and 50 healthy term control subjects were recruited to determine respiratory morbidity and spirometry. MEASUREMENTS AND MAIN RESULTS: Respiratory symptom questionnaire, spirometry, and methacholine challenge test. The index study group had significantly more respiratory symptoms (16 of 60) than did control subjects (4 of 50) (odds ratio, 4.2; 95% confidence interval, 1.3 to 13.5; P = 0.01), but no significant difference in measured spirometry. Specifically, in the index study group and control subjects, the mean z scores (95% confidence interval of the group difference) for the FEV(1) were -0.60 and -0.58 (-0.44 to 0.49), respectively (P = 0.92); for the forced mid-expiratory flow they were -1.02 and -0.86 (-0.33 to 0.64), respectively (P = 0.52); and for the FVC they were -0.29 and -0.33 (-0.46 to 0.38), respectively (P = 0.85). Ex-preterm adults did not show evidence of increased airway hyperresponsiveness compared with control subjects, 23 and 19%, respectively (P = 0.89). CONCLUSIONS: There are still excess respiratory symptoms 21 years after preterm birth. Reassuringly, this longitudinal study did not show evidence of persistent airway obstruction or airway hyperresponsiveness in ex-preterm adults.
Authors: Joseph Fawke; Sooky Lum; Jane Kirkby; Enid Hennessy; Neil Marlow; Victoria Rowell; Sue Thomas; Janet Stocks Journal: Am J Respir Crit Care Med Date: 2010-04-08 Impact factor: 21.405
Authors: E E Sarria; R Mattiello; L Rao; M R Wanner; M E Raske; C Tiller; R Kimmel; R S Tepper Journal: Eur Respir J Date: 2011-04-08 Impact factor: 16.671
Authors: Alexandra Heath-Freudenthal; Lilian Toledo-Jaldin; Inge von Alvensleben; Litzi Lazo-Vega; Rodrigo Mizutani; Margaret Stalker; Hussna Yasini; Fanny Mendizabal; Jesus Dorado Madera; William Mundo; Melany Castro-Monrroy; Julie A Houck; Any Moreno-Aramayo; Valquiria Miranda-Garrido; Emily J Su; Dino A Giussani; Steven H Abman; Lorna G Moore; Colleen G Julian Journal: Hypertension Date: 2022-04-19 Impact factor: 10.190
Authors: Eric C Walter; William J Ehlenbach; David L Hotchkin; Jason W Chien; Thomas D Koepsell Journal: Am J Respir Crit Care Med Date: 2009-04-16 Impact factor: 21.405
Authors: Michele Arigliani; Chiara Stocco; Elena Valentini; Carlo De Pieri; Luigi Castriotta; Maria Elena Ferrari; Cristina Canciani; Lorenza Driul; Maria Orsaria; Luigi Cattarossi; Paola Cogo Journal: Pediatr Res Date: 2021-01-19 Impact factor: 3.756